Long Term Follow-Up Study for rAAV-GAD Treated Subjects

TerminatedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2011

Conditions
Parkinson's Disease
Interventions
BIOLOGICAL

rAAV-GAD

Trial Locations (6)

27157

Wake Forest University Health Science Center, Winston-Salem

43210

The Ohio State University, Columbus

48034

Henry Ford Health Systems, Southfield

80045

University of Colorado, Aurora

94305-5401

Stanford University, Stanford

0211

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neurologix, Inc.

INDUSTRY